Skip to content

Validation of the NeuroTec Loft

Validation of an Apartment to Monitor Human Behaviour During Day and Night

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04793555
Enrollment
104
Registered
2021-03-11
Start date
2021-06-01
Completion date
2022-07-29
Last updated
2022-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Activities of Daily Living, Aging, Neurodegenerative Diseases

Brief summary

The progression of neurodegenerative disorders and the increasing number of elderly people intensifies the need of institutional care, which contrasts with the desire of most elderly and patients to live independently at home. The rapid evolution of assistive technology offers new possibilities in providing medical professionals preventive services in real-time. Therefore, the main focus of this study is on the individual sensors and how they can be combined to one unobtrusive system to assess the human behaviour and daily activities during day and night in an instrumented apartment in healthy participants.

Detailed description

The higher prevalence of age-associated neurodegenerative disorders (e.g. Parkinson, Alzheimer), is in line with a steady increase of the average life expectancy in Switzerland. With the progression of neurodegenerative disorders and the increasing number of elderly people, the need for institutional care intensifies, which contrasts with the desire of most elderly and patients to live independently. The rapid evolution of assistive technology offers new possibilities in providing medical professionals preventive services in real-time. An extended stay in the hospital could influence independent ageing negatively and thus, monitoring has great potential to prevent critical events. In this study, the main focus is on the individual sensors and how they can be combined to one unobtrusive system. In addition, to get an understanding which parameters of the sensors are important and how the data can be extracted and processed (algorithms). Therefore, the aim of this study is to validate the accuracy to assess human behaviour and daily activities during day and night by unobtrusive sensors in an instrumented apartment in healthy participants.

Interventions

OTHERMonitoring by unobtrusive sensors

During the study the behavior of daily activities will be monitored by unobstructive sensors. Most of the sensors will be mounted on the wall or on furniture with direct sight to the participant and thus will not have any physical contact, except some wearables during the stay in the apartment and at home (e.g. watch, mobile polysomnography).

Sponsors

Insel Gruppe AG, University Hospital Bern
CollaboratorOTHER
University of Bern
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Single-center prospective non-inferiority study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Written informed consent * Aged ≥18 years * German speaking

Exclusion criteria

* Infected by multidrug-resistant bacteria according to current medical history * Incontinence

Design outcomes

Primary

MeasureTime frameDescription
Heart rate (Vital parameters)1 Week / ContinuouslyThe heart rate will be continuously measured by pressure sensors, radar sensors, infrared camera, galvanic sensor and polysomnography (gold standard).
Skin conductance (Vital parameters)1 Week / ContinuouslyThe skin conductance will be continuously measured by pressure sensors, radar sensors, infrared camera, galvanic sensor and polysomnography (gold standard).
Systolic / Diastolic blood pressure (Vital parameters)1 Week / ContinuouslyThe blood pressure will be continuously measured by pressure sensors, radar sensors, infrared camera, galvanic sensor and polysomnography (gold standard).
Oxygen saturation (Vital parameters)1 Week / ContinuouslyThe oxygen saturation will be continuously measured by pressure sensors, radar sensors, infrared camera, galvanic sensor and polysomnography (gold standard).
Respiration rate (Vital parameters)1 Week / ContinuouslyThe respiration rate will be continuously measured by pressure sensors, radar sensors, infrared camera, galvanic sensor and polysomnography (gold standard).

Secondary

MeasureTime frameDescription
3D Model (Coordinates of the joints over time) of the participant in the apartment (Movement parameters)1 Week / ContinuouslyThe pose will be assessed continuously by pressure sensors, radar sensors, accelerometer, gyroscope, motion tracking (gold standard), lidar sensors, piir sensors.

Other

MeasureTime frameDescription
Brightness (Activities of daily living)1 Week / ContinuouslyUnit: Lux.
Accelerometer - Wearable (Activities of daily living)1 Week / ContinuouslyUnit: m/s\^2.
Electrocardiography (ECG) - Wearable (Activities of daily living)1 Week / ContinuouslyUnit: Component of the ECG (QRS Complex).
Cognition 1Measured on the first day / 1xCognition will be assessed by the Montreal Cognitive Assessment (MoCA). Scores of the MoCA range from 0 to 30, with a score of 26 and higher generally considered normal.
Cognition 2Measured on the first day / 1xCognition will be assessed by the Mini-Mental State Examination (MMSE). Scores of the MMSE range from 0 to 30, with a score of 25 and higher generally considered normal.
Health-related quality of lifeMeasured on the first and last day / 2xHealth-related quality of life will be assessed by the EuroQol (EQ-5D-5L).The EQ-5D-5L comprises five questions on mobility, self-care, pain, usual activities, and psychological status. The questions have five possible answers for each item (no problems - unable to).
Sleep qualityEach day / 7xSleep quality will be assessed by the SF A/R. The inventory estimates the total sleep duration (calculated from items 'bedtime in the evening' and 'wake-up time in morning'), time awake after sleep onset, and sleep onset latency (5-point Likert scale).
ChronotypeMeasured on the first day / 1xThe Chronotype will be assessed by the D-MEQ. The D-MEQ scores range between 13 and 86. High sum scores (59-86) are associated to morningness, while lower scores point to eveningness (16-41).
Depression 1Measured on the first day / 1xDepression will be assessed by the Geriatric Depression Scale (GDS). The inventory has 15 questions (yes/no). Scores of 0-4 are considered normal and 12-15 indicate severe depression.
Depression 2Measured on the first day / 1xDepression will be assessed by the Beck Depression Inventory (BDI). The inventory has 21 questions (yes/no). Scores of 1-10 are considered normal and over 40 indicate severe depression.
Physical activityMeasured on the first day / 1xPhysical activity will be assessed by the International Physical Activity Questionnaire (IPAQ). The IPAQ assesses the time spent on walking, doing moderate-intensity and vigorous-intensity activity within the domains of work, transportation, domestic and gardening (yard) activities, and leisure-related activities.
Grip strengthMeasured on the first day / 1xGrip strength will be assessed by a dynamometer.
Fall riskMeasured on the first day / 1xFall risk will be assessed by the Time Up and Go Test (TUG).
Gait and balanceMeasured on the first day / 1xGait and balance will be assessed by the Tinetti Balance and Gait Test (POMA).
Relative Humidity (Activities of daily living)1 Week / ContinuouslyUnit: Percent - Relative to a maximum humidity given the same temperature.
Temperature (Activities of daily living)1 Week / ContinuouslyUnit: Degree Celsius.
Power used - Power Plugs (Activities of daily living)1 Week / ContinuouslyUnit: Watt.
Doors open and closed (Activities of daily living)1 Week / ContinuouslyUnit: 1 open, 0 closed.
UsabilityEach day / 7xThe usability of the sensor system will be assessed by the System usability scale (SUS). The score range is between 0 and 100, whereas the higher score means higher usability.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026